News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation
Photo from Emanuele Ammatuna/LinkedIn
Nov 4, 2023, 00:28

Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation

Emanuele Ammatuna, Hematologist at University Medical Center Groningen, shared on LinkedIn:

“Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation. The addition of a bcl-2 inhibitor to HMA should be the next investigation in this category of patients.”

Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation

Source: Emanuele Ammatuna/LinkedIn

bcl-2 inhibitor cancer decitabine Emanuele Ammatuna OncoDaily Oncology Stem Cell Transplantation
Special Coverage
Blog
Feb 27, 2025, 09:01
Last Chance to Register for the ESTRO School 2025 Lower GI course
Blog
Feb 27, 2025, 08:53
Paul Peter Tak: Positive final survival data from CAN-2409 in borderline resectable pancreatic cancer
Blog
Feb 27, 2025, 08:38
Michael Sapienza: Committed to ensuring that colorectal cancer remains a national priority
Blog
Feb 27, 2025, 08:31
World NGO Day 2025: 'Empowering Grassroots Movements for a Sustainable Future' - Lung Cancer Europe
Blog
Feb 27, 2025, 08:25
Antonio Passaro: I had the opportunity to participate in the Immuno Oncology South Africa
Blog
Feb 27, 2025, 08:16
Ashika Naik: Honoring the unwavering commitment of non-governmental organizations
Insight
Feb 27, 2025, 08:02
AMORE Project: Using Big Data to Improve Cancer Care Accessibility in Urban Areas
Blog
Feb 27, 2025, 07:45
Miriam Mutebi: Awareness must lead to action
Oncolibrary
Feb 26, 2025, 18:07
Ocular Side Effects of Chemotherapy: Understanding the Risks of Eye Toxicity
Blog
Feb 26, 2025, 16:35
Toral Shah: World cancer day 2025 reflections – Why is Integrative oncology important?
Science
Feb 26, 2025, 16:33
Hagop Kantarjian: Treatment-free remission in non-transplanted Ph+ ALL patients
Blog
Feb 26, 2025, 16:33
Iván R. González: Neoadjuvant Nivolumab Plus Ipilimumab versus Chemotherapy in Patients with Resectable NSCLC